SARCOMA CONNECT Update from ESMO 2019
SARCOMA CONNECT Update from ESMO 2019
Prof. Sebastian Bauer
SARCOMA CONNECT has summarised highlights of the recent ESMO 2019 meeting for youProf. Sebastian Bauer
Medical Oncologist
Sarcoma Center, West German Cancer Center, University Hospital Essen
Germany
Sebastian Bauer (MD) underwent his medical training at the University of Würzburg, Germany and his resisdency and medical oncology fellowship at the University of Duisburg-Essen, Germany. He is committed to clinical care, clinical research and translational, lab-based research in sarcomas. He is Professor of Translational Oncology (Personalized Cancer Therapy) at the Dept. of Medical Oncology, University Hospital Essen as well as Director of the Sarcoma Center at the West German Tumor Center, one of the largest sarcoma programs in Europe. Dr Bauer has served as principal investigator in more than 50 clinical trials in bone, soft-tissue sarcomas, including gastrointestinal stromal tumors. His research group is focused on model development, resistance mechanisms to targeted treatments (primarily in GIST) and academic drug development. He is member of the steering committee of the German Sarcoma Study Group (AIO), member of the EORTC (STBSG) and board member of the German Sarcoma Foundation. He has in the past served as ESMO sarcoma track chair and is currently member of the sarcoma sub-committee. He is a regular reviewer for cancer-related journals and sarcoma meetings (CTOS, ESMO).
|
5 min
|
2019
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
SARCOMA CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.